The addition of a U.S. site will allow SciSparc to accelerate trial recruitment and further development of novel treatments for patients in need
Read more at globenewswire.comSciSparc Signs Clinical Trial Agreement with Yale University to Conduct its Phase IIb Trial in Tourette Syndrome
Globe Newswire -
Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here